The Tracking and Evaluation (TE) Core of the West Virginia Clinical and Translational Science Institute (WVCTSI) uses collaborative capacity building evaluation and accountability frameworks to assist all cores in their evaluation and data-based decision-making processes, empowering core personnel to recognize and address challenges to productivity and desired outcomes. During Years 1-5, TE established robust systems and processes to provide leadership and personnel with objective performance data to assess progress toward Aim achievement. In this renewal application, TE proposes innovative new initiatives to enhance the WVCTSI's capacity to evaluate its progress, maximizing accountability and programmatic improvement. These efforts will be accomplished through the following specific aims: 1) develop Investigator Tracking and Support System (ITSS) utilizing quantitative and qualitative approaches to identify factors either contributing to success or providing barriers to productivity, 2) create and implement a systematic set of tools and measurement to drive continuous quality improvement and demonstrate impact of community stakeholder participation and engagement, and 3) build focused research and evaluation demonstrating WVCTSI impacts on health outcomes in WV. To accomplish Aim 1, we have successfully piloted innovative software and standard operating procedures through which every instance of investigator service delivery is logged in a central database with all other individual investigator data points, and goals associated with the outcomes and products associated with that delivery.
For Aim 2, we will capture the breadth and depth of WVCTSI community stakeholder by evaluating associated activities, interactions, and outcomes using the i) Program to Analyze, Record, and Track Networks to Enhance Relationships (PARTNER) Tool, an online survey instrument, ii) Toolkit for Community Engaged Mapping, a qualitative tool, and iii) Collaborative Productivity Scale, expanded to include measures of an investigator's readiness to engage in Community Based Participatory Research (CBPR).
Aim 3 will involve transforming our existing evaluation system to focus on WVCTSI impact on health outcomes at three levels: 1) moving the needle on publicly-available statewide health outcomes, 2) evaluating WVCTSI resource allocation to impact WVCTSI priority areas and related outcomes, and 3) studying the impact of specific healthcare policy and practice changes disseminated across the WV Practice-Based Research Network (WVPBRN). At each of these levels, we will focus on WVCTSI priority area metrics including drug overdose deaths, cancer mortality, and cardiovascular mortality as well as a number of more intermediary outcomes (e.g., Hepatitis C cures, cancer stage at diagnosis). Integrating these innovations into programmatic evaluation processes and procedures developed during Years 1-5 will facilitate accomplishment of the new programmatic goals of this application.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
5U54GM104942-04
Application #
9756384
Study Section
Special Emphasis Panel (ZGM1)
Project Start
Project End
Budget Start
2019-07-01
Budget End
2020-06-30
Support Year
4
Fiscal Year
2019
Total Cost
Indirect Cost
Name
West Virginia University
Department
Type
DUNS #
191510239
City
Morgantown
State
WV
Country
United States
Zip Code
26506
Hou, Bob L; Wen, Sijin; Katsevman, Gennadiy A et al. (2018) MRI Parameters and Their Impact on the Survival of Patients with Glioblastoma: Tumor Perfusion Predicts Survival. World Neurosurg :
Xu, Jian; Li, Xue; Cole, Allison et al. (2018) Reduced Cell Division Control Protein 42 Activity Compromises Hematopoiesis-Supportive Function of Fanconi Anemia Mesenchymal Stromal Cells. Stem Cells 36:785-795
Jacobson, Geraldine; Chuang, Linus; Pankow, Maximilian (2018) Improving quality of care and timely access to radiation therapy for patients with invasive cervical cancer at the National Cancer Institute Paraguay. Gynecol Oncol Rep 25:82-86
Hu, Xian; Urhie, Ogaga; Chang, Kevin et al. (2018) A Novel Method for Training Mice in Visuo-Tactile 3-D Object Discrimination and Recognition. Front Behav Neurosci 12:274
Basco Jr, William T; Roberts, James R; Ebeling, Myla et al. (2018) Indications for Use of Combination Acetaminophen/Opioid Drugs in Infants <6 Months Old. Clin Pediatr (Phila) 57:741-744
Loso, Jennifer; Staub, Daniel; Colby, Sarah E et al. (2018) Gardening Experience Is Associated with Increased Fruit and Vegetable Intake among First-Year College Students: A Cross-Sectional Examination. J Acad Nutr Diet 118:275-283
Nair, Rajesh R; Piktel, Debbie; Geldenhuys, Werner J et al. (2018) Combination of cabazitaxel and plicamycin induces cell death in drug resistant B-cell acute lymphoblastic leukemia. Leuk Res 72:59-66
Grisez, Brian T; Ray, Justin J; Bostian, Phillip A et al. (2018) Highly metastatic K7M2 cell line: A novel murine model capable of in vivo imaging via luciferase vector transfection. J Orthop Res :
Komarov, Denis A; Ichikawa, Yuki; Yamamoto, Kumiko et al. (2018) In Vivo Extracellular pH Mapping of Tumors Using Electron Paramagnetic Resonance. Anal Chem :
Mündel, Toby; Olfert, I Mark (2018) Nicotine and exercise performance: another tool in the arsenal or curse for anti-doping? Eur J Appl Physiol 118:679-680

Showing the most recent 10 out of 998 publications